Resident fibroblast expansion during cardiac growth and remodeling

Journal of Molecular and Cellular Cardiology

Volumn 114, Issue , 2018, Pages 161-174

  Ivey, Malina J ^a   Kuwabara, Jill T ^a   Pai, Jonathan T ^a   Moore, Richard E ^a   Sun, Zuyue ^a   Tallquist, Michelle D ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Cardiac fibroblast; Endothelial cell; Fibrosis; Proliferation

Indexed keywords

ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ALPHA SMOOTH MUSCLE ACTIN; CD146 ANTIGEN; COLLAGEN; COLLAGEN TYPE 1A1; HERMES ANTIGEN; ISOLECTIN B4; ISOPRENALINE; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; VIMENTIN; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; BETA ADRENERGIC RECEPTOR; TCF21 PROTEIN, MOUSE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CELL DENSITY; CELL EXPANSION; CELL LINEAGE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HEART DEVELOPMENT; HEART FIBROBLAST; HEART INFARCTION; HEART INJURY; HEART VENTRICLE REMODELING; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; C57BL MOUSE; CELL LINE; DRUG EFFECT; FIBROBLAST; GROWTH, DEVELOPMENT AND AGING; HEART; METABOLISM; NEWBORN; PATHOLOGY; PRESSURE;

ANIMALS; ANIMALS, NEWBORN; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE; CELL LINEAGE; CELL PROLIFERATION; COLLAGEN; ENDOTHELIAL CELLS; FEMALE; FIBROBLASTS; HEART; ISOPROTERENOL; MALE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; PRESSURE; RECEPTORS, ADRENERGIC, BETA; VENTRICULAR REMODELING;

EID: 85034814836     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2017.11.012     Document Type: Article

References (62)

1. Weber, K.T., Sun, Y., Bhattacharya, S.K., Ahokas, R.A., Gerling, I.C., Myofibroblast-mediated mechanisms of pathological remodelling of the heart. Nat. Rev. Cardiol. 10 (2013), 15–26.
2. Kanisicak, O., Khalil, H., Ivey, M.J., Karch, J., Maliken, B.D., Correll, R.N. et al., Genetic lineage tracing defines myofibroblast origin and function in the injured heart. Nat. Commun., 7, 2016, 12260.
3. Molkentin, J.D., Bugg, D., Ghearing, N., Dorn, L.E., Kim, P., Sargent, M.A. et al., Fibroblast-specific genetic manipulation of p38 MAPK in vivo reveals its central regulatory role in fibrosis. Circulation 136 (2017), 549–561.
4. Kaur, H., Takefuji, M., Ngai, C., Carvalho, J., Bayer, J., Wietelmann, A. et al., Targeted ablation of Periostin-expressing activated fibroblasts prevents adverse cardiac remodeling in mice. Circ. Res. 118:12 (2016), 1906–1917.
5. Gourdie, R.G., Dimmeler, S., Kohl, P., Novel therapeutic strategies targeting fibroblasts and fibrosis in heart disease. Nat. Rev. Drug Discov. 15 (2016), 620–638.
6. Gabbiani, G., Evolution and clinical implications of the myofibroblast concept. Cardiovasc. Res. 38 (1998), 545–548.
7. Stempien-Otero, A., Kim, D.H., Davis, J., Molecular networks underlying myofibroblast fate and fibrosis. J. Mol. Cell. Cardiol. 97 (2016), 153–161.
8. Moore-Morris, T., Guimaraes-Camboa, N., Banerjee, I., Zambon, A.C., Kisseleva, T., Velayoudon, A. et al., Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis. J. Clin. Invest. 124 (2014), 2921–2934.
9. Pinto, A.R., Ilinykh, A., Ivey, M.J., Kuwabara, J.T., D'Antoni, M.L., Debuque, R. et al., Revisiting cardiac cellular composition. Circ. Res. 118 (2016), 400–409.
10. Ali, S.R., Ranjbarvaziri, S., Talkhabi, M., Zhao, P., Subat, A., Hojjat, A. et al., Developmental heterogeneity of cardiac fibroblasts does not predict pathological proliferation and activation. Circ. Res. 115 (2014), 625–635.
11. Song, K., Nam, Y.J., Luo, X., Qi, X., Tan, W., Huang, G.N. et al., Heart repair by reprogramming non-myocytes with cardiac transcription factors. Nature 485 (2012), 599–604.
12. Nag, A.C., Study of non-muscle cells of the adult mammalian heart: a fine structural analysis and distribution. Cytobios 28 (1980), 41–61.
13. Doppler, S.A., Carvalho, C., Lahm, H., Deutsch, M.A., Dressen, M., Puluca, N. et al., Cardiac fibroblasts: more than mechanical support. J. Thorac. Dis. 9 (2017), S36–S51.
14. Jiang, J., Burgon, P.G., Wakimoto, H., Onoue, K., Gorham, J.M., O'Meara, C.C. et al., Cardiac myosin binding protein C regulates postnatal myocyte cytokinesis. Proc. Natl. Acad. Sci. U. S. A. 112 (2015), 9046–9051.
15. Soonpaa, M.H., Kim, K.K., Pajak, L., Franklin, M., Field, L.J., Cardiomyocyte DNA synthesis and binucleation during murine development. Am. J. Phys. 271 (1996), H2183–9.
16. Walsh, S., Ponten, A., Fleischmann, B.K., Jovinge, S., Cardiomyocyte cell cycle control and growth estimation in vivo—an analysis based on cardiomyocyte nuclei. Cardiovasc. Res. 86 (2010), 365–373.
17. Acharya, A., Baek, S.T., Banfi, S., Eskiocak, B., Tallquist, M.D., Efficient inducible Cre-mediated recombination in Tcf21 cell lineages in the heart and kidney. Genesis 49 (2011), 870–877.
18. Hamilton, T.G., Klinghoffer, R.A., Corrin, P.D., Soriano, P., Evolutionary divergence of platelet-derived growth factor alpha receptor signaling mechanisms. Mol. Cell. Biol. 23 (2003), 4013–4025.
19. Yata, Y., Scanga, A., Gillan, A., Yang, L., Reif, S., Breindl, M. et al., DNase I-hypersensitive sites enhance alpha1(I) collagen gene expression in hepatic stellate cells. Hepatology 37 (2003), 267–276.
20. Madisen, L., Zwingman, T.A., Sunkin, S.M., SW, Oh., Zariwala, H.A., Gu, H. et al., A robust and high-throughput CRE reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13 (2010), 133–140.
21. Acharya, A., Baek, S.T., Huang, G., Eskiocak, B., Goetsch, S., Sung, C.Y. et al., The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors. Development 139 (2012), 2139–2149.
22. Smith, C.L., Baek, S.T., Sung, C.Y., Tallquist, M.D., Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling. Circ. Res. 108 (2011), e15–26.
23. Halfon, S., Abramov, N., Grinblat, B., Ginis, I., Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging. Stem Cells Dev. 20 (2011), 53–66.
24. Carlson, S., Trial, J., Soeller, C., Entman, M.L., Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction. Cardiovasc. Res. 91 (2011), 99–107.
25. Bayes-Genis, A., Soler-Botija, C., Farre, J., Sepulveda, P., Raya, A., Roura, S. et al., Human progenitor cells derived from cardiac adipose tissue ameliorate myocardial infarction in rodents. J. Mol. Cell. Cardiol. 49 (2010), 771–780.
26. Li, F., Wang, X., Capasso, J.M., Gerdes, A.M., Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. J. Mol. Cell. Cardiol. 28 (1996), 1737–1746.
27. Hirai, M., Chen, J., Evans, S.M., Tissue-specific cell cycle indicator reveals unexpected findings for cardiac myocyte proliferation. Circ. Res. 118 (2016), 20–28.
28. Banerjee, I., Fuseler, J.W., Price, R.L., Borg, T.K., Baudino, T.A., Determination of cell types and numbers during cardiac development in the neonatal and adult rat and mouse. Am. J. Physiol. Heart Circ. Physiol. 293 (2007), H1883–91.
29. Ieronimakis, N., Hays, A., Prasad, A., Janebodin, K., Duffield, J.S., Reyes, M., PDGFRalpha signalling promotes fibrogenic responses in collagen producing cells in Duchenne muscular dystrophy. J. Pathol., 2016.
30. Tallquist, M.D., Molkentin, J.D., Redefining the identity of cardiac fibroblasts. Nat. Rev. Cardiol., 2017.
31. Brooks, W.W., Conrad, C.H., Isoproterenol-induced myocardial injury and diastolic dysfunction in mice: structural and functional correlates. Comp. Med. 59 (2009), 339–343.
32. Benjamin, I.J., Jalil, J.E., Tan, L.B., Cho, K., Weber, K.T., Clark, W.A., Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ. Res. 65 (1989), 657–670.
33. Fatkhudinov, T., Bolshakova, G., Arutyunyan, I., Elchaninov, A., Makarov, A., Kananykhina, E. et al., Bone marrow-derived multipotent stromal cells promote myocardial fibrosis and reverse remodeling of the left ventricle. Stem Cells Int., 2015, 2015, 746873.
34. Williams, S.M., Golden-Mason, L., Ferguson, B.S., Schuetze, K.B., Cavasin, M.A., Demos-Davies, K. et al., Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes. J. Mol. Cell. Cardiol. 67 (2014), 112–125.
35. Squires, C.E., Escobar, G.P., Payne, J.F., Leonardi, R.A., Goshorn, D.K., Sheats, N.J. et al., Altered fibroblast function following myocardial infarction. J. Mol. Cell. Cardiol. 39 (2005), 699–707.
36. Talman, V., Ruskoaho, H., Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell Tissue Res. 365 (2016), 563–581.
37. Brilla, C.G., Pick, R., Tan, L.B., Janicki, J.S., Weber, K.T., Remodeling of the rat right and left ventricles in experimental hypertension. Circ. Res. 67 (1990), 1355–1364.
38. Weber, K.T., Brilla, C.G., Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 83 (1991), 1849–1865.
39. Jalil, J.E., Doering, C.W., Janicki, J.S., Pick, R., Shroff, S.G., Weber, K.T., Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ. Res. 64 (1989), 1041–1050.
40. De Jong, A.M., Van Gelder, I.C., Vreeswijk-Baudoin, I., Cannon, M.V., Van Gilst, W.H., Maass, A.H., Atrial remodeling is directly related to end-diastolic left ventricular pressure in a mouse model of ventricular pressure overload. PLoS One, 8, 2013, e72651.
41. Skosey, J.L., Zak, R., Martin, A.F., Aschenbrenner, V., Rabinowitz, M., Biochemical correlates of cardiac hypertrophy. V. Labeling of collagen, myosin, and nuclear DNA during experimental myocardial hypertrophy in the rat. Circ. Res. 31 (1972), 145–157.
42. Morkin, E., Ashford, T.P., Myocardial, D.N.A., Synthesis in experimental cardiac hypertrophy. Am. J. Phys. 215 (1968), 1409–1413.
43. Zak, R., Development and proliferative capacity of cardiac muscle cells. Circ. Res. 35:suppl II (1974), 17–26.
44. Burstein, B., Libby, E., Calderone, A., Nattel, S., Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 117 (2008), 1630–1641.
45. Fredj, S., Bescond, J., Louault, C., Delwail, A., Lecron, J.C., Potreau, D., Role of interleukin-6 in cardiomyocyte/cardiac fibroblast interactions during myocyte hypertrophy and fibroblast proliferation. J. Cell. Physiol. 204 (2005), 428–436.
46. + currents regulate the resting membrane potential, proliferation, and contractile responses in ventricular fibroblasts and myofibroblasts. Am. J. Physiol. Heart Circ. Physiol. 288 (2005), H2931–9.
47. Alkass, K., Panula, J., Westman, M., TD, Wu, Guerquin-Kern, J.L., Bergmann, O., No evidence for cardiomyocyte number expansion in preadolescent mice. Cell 163 (2015), 1026–1036.
48. Olivetti, G., Anversa, P., Loud, A.V., Morphometric study of early postnatal development in the left and right ventricular myocardium of the rat. II. Tissue composition, capillary growth, and sarcoplasmic alterations. Circ. Res. 46 (1980), 503–512.
49. Reiss, K., Cheng, W., Kajstura, J., Sonnenblick, E.H., Meggs, L.G., Anversa, P., Fibroblast proliferation during myocardial development in rats is regulated by IGF-1 receptors. Am. J. Phys. 269 (1995), H943–51.
50. Williams, C., Quinn, K.P., Georgakoudi, I., Black, L.D. 3rd, Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro. Acta Biomater. 10 (2014), 194–204.
51. Bergmann, O., Zdunek, S., Felker, A., Salehpour, M., Alkass, K., Bernard, S. et al., Dynamics of cell generation and turnover in the human heart. Cell 161 (2015), 1566–1575.
52. Frangogiannis, N.G., Michael, L.H., Entman, M.L., Myofibroblasts in reperfused myocardial infarcts express the embryonic form of smooth muscle myosin heavy chain (SMemb). Cardiovasc. Res. 48 (2000), 89–100.
53. Frangogiannis, N.G., Perrard, J.L., Mendoza, L.H., Burns, A.R., Lindsey, M.L., Ballantyne, C.M. et al., Stem cell factor induction is associated with mast cell accumulation after canine myocardial ischemia and reperfusion. Circulation 98 (1998), 687–698.
54. Souders, C.A., Borg, T.K., Banerjee, I., Baudino, T.A., Pressure overload induces early morphological changes in the heart. Am. J. Pathol. 181 (2012), 1226–1235.
55. Virag, J.I., Murry, C.E., Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am. J. Pathol. 163 (2003), 2433–2440.
56. Takemura, G., Ohno, M., Hayakawa, Y., Misao, J., Kanoh, M., Ohno, A. et al., Role of apoptosis in the disappearance of infiltrated and proliferated interstitial cells after myocardial infarction. Circ. Res. 82 (1998), 1130–1138.
57. Jose Corbalan, J., Vatner, D.E., Vatner, S.F., Myocardial apoptosis in heart disease: does the emperor have clothes?. Basic Res. Cardiol., 111, 2016, 31.
58. Chen, B., Frangogiannis, N.G., Immune cells in repair of the infarcted myocardium. Microcirculation, 24, 2017.
59. Chen, W., Frangogiannis, N.G., Fibroblasts in post-infarction inflammation and cardiac repair. Biochim. Biophys. Acta 1833 (2013), 945–953.
60. Nahrendorf, M., Pittet, M.J., Swirski, F.K., Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121 (2010), 2437–2445.
61. Frangogiannis, N.G., The mechanistic basis of infarct healing. Antioxid. Redox Signal. 8 (2006), 1907–1939.
62. Ruiz-Villalba, A., Simon, A.M., Pogontke, C., Castillo, M.I., Abizanda, G., Pelacho, B. et al., Interacting resident epicardium-derived fibroblasts and recruited bone marrow cells form myocardial infarction scar. J. Am. Coll. Cardiol. 65 (2015), 2057–2066.